Skip to content

Clinical trials

Recruiting Phase 2 Fatty Liver trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fatty Liver Phase: Phase 2 Status: Recruiting Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20222
20231
20243
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Adrian Vella1
Ain Shams University1
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1
GlaxoSmithKline1
Hinova Pharmaceuticals Inc.1
Hudson Biotech1
McMaster University1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
University Hospitals Cleveland Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fatty Liver9
Non-alcoholic Fatty Liver Disease7
Fibrosis1
Inflammation1
Insulin Resistance1
Liver Cirrhosis1
Liver Diseases1
Liver Diseases, Alcoholic1
Obesity1
Overweight1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.